Consumer staples ETFs have drawn renewed attention as investors seek defensive sector exposure amid persistent macro uncertainty. GXPS, IYK, and RSPS all provide access to U.S. companies selling food, beverages, household products, and other everyday essentials, yet they are not interchangeable. They represent three distinct approaches to the same theme: uncapped market-cap weighting, a capped benchmark with a defensive healthcare slant, and equal weighting. Understanding these structural differences — rather than short-term price swings — is essential for assessing fund performance and relative positioning. When screening similar options, I also checked this using Tickeron’s AI Screener to see how the holdings align across the sector.
GXPS is a newer entrant in the Global X PureCap suite, seeking to provide uncapped, market-capitalization-weighted exposure to the U.S. consumer staples sector. Unlike many sector funds that cap individual security weights, GXPS deliberately allows the largest constituents to dominate, reflecting the sector's true market-cap composition. This design favors mega-cap staples leaders, meaning a substantial portion of assets sits in companies such as Procter & Gamble (PG), Coca-Cola (KO), PepsiCo (PEP), and Philip Morris International (PM). The fund is non-diversified, which can heighten concentration risk. Its relatively short track record and uncapped structure make it a purer — but potentially more volatile — expression of large-cap staples.
Launched in 2000, IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, which caps individual holdings to limit concentration. The fund holds roughly 54–57 securities and carries an expense ratio of about 0.37–0.38%. Its largest positions include Procter & Gamble (PG), Coca-Cola (KO), Philip Morris International (PM), and PepsiCo (PEP), with the top 10 holdings accounting for roughly two-thirds of assets. A defining feature is its sector mix: food, beverage, and tobacco dominate (over 55%), followed by household and personal products, but the fund also includes a meaningful allocation to healthcare names such as CVS Health (CVS) and McKesson (MCK). This adds a secondary defensive layer beyond pure staples.
RSPS, launched in 2006, tracks the S&P 500 Equal Weight Consumer Staples Index, giving every constituent an equal allocation of roughly 2–3%. The fund holds approximately 36–39 large-cap U.S. staples stocks and charges an expense ratio of 0.40%. Because it equal-weights, RSPS tilts exposure away from mega caps and toward mid-tier names such as Dollar Tree (DLTR), Target (TGT), Hormel Foods (HRL), Kimberly-Clark (KMB), and General Mills (GIS). The top 10 holdings represent only about 29% of assets, sharply reducing single-stock concentration risk. This structure can dilute the influence of strong performers but also provides more balanced sector exposure.
The consumer staples sector remains a favored defensive allocation in an environment shaped by elevated inflation, shifting consumer spending, and geopolitical uncertainty. Staples companies typically offer resilient earnings and steady dividends, but they face margin pressure from input costs and competition from private-label brands. Regulatory and health-related scrutiny of tobacco and beverage companies, currency headwinds for multinationals, and changing retail dynamics — including the rise of discount retailers — all influence the sector's largest holdings. Capital flows into defensive equity have been mixed in recent quarters, reflecting investor debate between seeking stability and chasing growth-oriented sectors.
Over recent months, the three funds have diverged in ways that reflect their construction. IYK's capped structure and healthcare overlay have historically contributed to lower beta and more contained drawdowns relative to broader equities, supporting steadier relative positioning. GXPS, as an uncapped fund, concentrates returns in the sector's biggest names, which can amplify both upside and downside. RSPS's equal weighting has at times lagged market-cap-weighted peers when mega caps lead, while offering more resilience when mid-tier staples outperform. RSPS also carries a higher fee and a smaller asset base, which can translate into slightly wider trading spreads and lower liquidity than the larger IYK. From what I see, these differences become clearer when running quick comparisons through available screening tools.
Based on observable structural characteristics rather than short-term price action, Tickeron's AI would most likely favor IYK. Its larger and more diversified holdings base, slightly lower expense ratio, longer operating history, and defensive healthcare overlay support more stable momentum and stronger risk-adjusted positioning relative to GXPS and RSPS. While GXPS offers a purer large-cap staples bet and RSPS provides equal-weight diversification, IYK balances concentration, cost, liquidity, and diversification most effectively among the three, making it the most probable candidate for sustained, defensible exposure.
In my own analysis of sector ETFs like these, I frequently use Tickeron’s AI Screener to filter holdings by industry, volatility, and performance metrics. It helps surface patterns across thousands of securities quickly and supports more informed comparisons without manual effort. The tool has become a regular part of reviewing defensive allocations such as consumer staples.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows